1.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

2.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

3.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

4.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

5.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

6.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

7.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

8.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

9.

Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.

1.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

2.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

3.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

4.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

5.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

6.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

7.

Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort.

1.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

2.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

3.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

4.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

5.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

6.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

7.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

8.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

9.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

1.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

2.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

3.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

4.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

5.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

6.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

7.

Incremental value of intact fibroblast growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patients.

1.

Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility : fol...

1.

Comparison of registries of interstitial lung diseases in three European countries

2.

Comparison of registries of interstitial lung diseases in three European countries

3.

Comparison of registries of interstitial lung diseases in three European countries

1.

Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

2.

Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

3.

Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

1.

Prospective five-year subsidence analysis of a cementless fully hydroxyapatite-coated femoral hip arthroplasty component

2.

Prospective five-year subsidence analysis of a cementless fully hydroxyapatite-coated femoral hip arthroplasty component

3.

Prospective five-year subsidence analysis of a cementless fully hydroxyapatite-coated femoral hip arthroplasty component

1.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

2.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

3.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

4.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

5.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

6.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

7.

A national cohort of HIV-infected patients in Belgium: design and main characteristics.

1.

Cancer pendant la grossesse: importance d'un registre national et Européen. ; Cancer diagnosis during pregnancy: importance of a national and European registration.

2.

Cancer pendant la grossesse: importance d'un registre national et Européen. ; Cancer diagnosis during pregnancy: importance of a national and European registration.

3.

Cancer pendant la grossesse: importance d'un registre national et Européen. ; Cancer diagnosis during pregnancy: importance of a national and European registration.